Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Testosterone Replacement Therapy in Urologic Surgery
NCT04731376Phase 1Active, not recruiting
- Sponsor
- Emory University
- Start
- Jan 2021
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of testosterone cypionate in Hypogonadism (2 arms), sponsored by Emory University. Primary endpoints: Quality of Life at 3 months, Frailty Phenotype at 90 days and 8 more. Started Jan 2021; status: active, not recruiting.
02
Drugs
testosterone cypionate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT04731376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04731376.